Afatinib-[d4]

Ask supplier a question | View on supplier's website

Labelled Afatinib. Afatinib is a medication approved for the treatment of metastatic non-small cell lung cancer (NSCLC) that has certain EGFR mutations. It acts via inhibiting EGFR and HER2.

Supplier	BOC Sciences
Product #	BLP-003532
Pricing	Inquire
Molecular Weight	489.97
Molecular Formula	C24H21D4ClFN5O3
Canonical SMILES	CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4

Feedback